Vibegron demonstrates favorable safety and tolerability, with common adverse effects including headache, nasopharyngitis, and diarrhea
Its interaction with opioid systems may also contribute to pain relief and further stress reduction, highlighting its potential therapeutic applications
in the Yale study, patients who have undergone Reiki treatment perceived improved emotional state
Combining natural compounds with adjuvants or using them as an adjunct to conventional treatment are promising strategies to optimize outcomes (Sakshi et al., 2023)
A Phase 2 trial for HIV-associated lipodystrophy was discontinued in 2006-2007 after a participant death, and development was never resumed
ProHealth packages this into a supplement format with the intent of making it accessible to the general public